Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lothar Biesert"'
Autor:
Elisabeth Casademunt, Mats Jernberg, Lothar Biesert, Carola Schröder, Sigurd Knaub, Maya Tiemeyer, Stefan Winge, Olaf Walter, Kristina Martinelle
Publikováno v:
European Journal of Haematology
Introduction Since the early 1990s, recombinant human clotting factor VIII (rhFVIII) produced in hamster cells has been available for haemophilia A treatment. However, the post-translational modifications of these proteins are not identical to those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b25de3b840bec4536265cdd66a0b762
http://europepmc.org/articles/PMC3443369
http://europepmc.org/articles/PMC3443369
Autor:
Fabrizio Fabbrizzi, Lothar Biesert, Gerhard Pölsler, Herbert O. Dichtelmüller, Eckhard Flechsig, Albrecht Gröner, Nathan J. Roth, Christoph Kempf, Ilka von Hoegen, Anna Falbo, Thomas R. Kreil, Douglas C. Lee
Publikováno v:
Transfusion. 51:1412-1430
BACKGROUND: Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6c10033a2447ed32e78638667ef55eb
https://doi.org/10.1111/j.1537-2995.2010.03003.x
https://doi.org/10.1111/j.1537-2995.2010.03003.x
Autor:
Rodriguez Gajardo, Christoph Kempf, Ilka von Hoegen, Thomas R. Kreil, Fabrizzio Fabbrizzi, Dominique Pifat, Albrecht Gröner, Wendy Osheroff, Juan I. Jorquera, Gerhard Poelsler, Herbert O. Dichtelmüller, Lothar Biesert
Publikováno v:
Transfusion. 49:1931-1943
BACKGROUND: Solvent/detergent (S/D) treatment is an established virus inactivation technology that has been applied in the manufacture of medicinal products derived from human plasma for more than 20 years. Data on the inactivation of enveloped virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::494daa7125368af584c885109dddea79
https://doi.org/10.1111/j.1537-2995.2009.02222.x
https://doi.org/10.1111/j.1537-2995.2009.02222.x
Autor:
Tor-Einar Svae, Torben Schmidt, Herwig Reichl, Jürgen Römisch, Andrea Neisser-Svae, Andrea Heger, Lothar Biesert, Andrew Bailey
Publikováno v:
Transfusion and Apheresis Science. 39:59-67
Reports about transfusion-related transmissions of variant Creutzfeldt-Jakob disease have urged the need for more information regarding the risk for prion contaminated units in the blood supply and the safety of transfusion plasma and biopharmaceutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5cf8b01d84c3e52010a8f6e6c29d93
https://doi.org/10.1016/j.transci.2008.05.006
https://doi.org/10.1016/j.transci.2008.05.006
Publikováno v:
Production of Plasma Proteins for Therapeutic Use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6ce02fad1cf8ab58b4e8a3e066ef4dc
https://doi.org/10.1002/9781118356807.ch25
https://doi.org/10.1002/9781118356807.ch25
Autor:
Herbert O, Dichtelmüller, Lothar, Biesert, Fabrizio, Fabbrizzi, Anna, Falbo, Eckhard, Flechsig, Albrecht, Gröner, Ilka, von Hoegen, Christoph, Kempf, Thomas R, Kreil, Douglas C, Lee, Gerhard, Pölsler, Nathan J, Roth
Publikováno v:
Transfusion. 51(7)
Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in those cases w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c011d0a67645d4aa8a032a6b2a25948
https://pubmed.ncbi.nlm.nih.gov/21251002
https://pubmed.ncbi.nlm.nih.gov/21251002
Autor:
Herbert O. Dichtelmüller, Fabrizio Fabbrizzi, Albrecht Gröner, I. Von Hoegen, Kang Cai, Dominique Pifat, Steve Petteway, P. A. Bauman, Rodrigo Gajardo, Thomas R. Kreil, Lothar Biesert, Juan I. Jorquera, L. A. Lawrence, Christoph Kempf
Publikováno v:
Vox sanguinis. 91(1)
Background and Objectives Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases caused by aberrantly folded cellular proteins (PrPSc; prions) that are generally resistant to conventional pathogen-inactivation technique
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3af0487ebabf24aefb7e2a843dc99f7
https://pubmed.ncbi.nlm.nih.gov/16756599
https://pubmed.ncbi.nlm.nih.gov/16756599
Publikováno v:
Biologicals
SARS-coronavirus (SARS-CoV) is a newly emerged, highly pathogenic agent that caused over 8000 human infections with nearly 800 deaths between November 2002 and September 2003. While direct person-to-person transmission via respiratory droplets accoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1968e6adb6d7020475f7a4208eb1ab0
https://pubmed.ncbi.nlm.nih.gov/15939287
https://pubmed.ncbi.nlm.nih.gov/15939287
Publikováno v:
Seminars in Thrombosis and Hemostasis. 33:215-216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfcc10df9fbbaf3cee5672d646683c5c
https://doi.org/10.1055/s-2007-969037
https://doi.org/10.1055/s-2007-969037
Autor:
Aleš Štrancar, Lutz Hoffer, Horst Schwinn, Lothar Biesert, Petra Schulz, Djuro Josic, Mira Kordis-Krapez
Publikováno v:
Journal of chromatography. B, Biomedical sciences and applications. 694(2)
Product development and process validation are shown in the case of several products obtained from human plasma. These are virus-inactivated plasma, intravenous immunoglobulins and the clotting factors VIII and IX. Different analytical methods are pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b9f9e9b1e1bda7cf15d22cacbd7948
https://pubmed.ncbi.nlm.nih.gov/9252039
https://pubmed.ncbi.nlm.nih.gov/9252039